Altcoins News
By Sakamoto Nashi
1 / 13
From Biotechnology to Ethereum Treasury Powerhouse. Originally launched as Life Sciences Corp in 2016, the Nasdaq-listed biotechnology company faced…
2 / 13
Strategic Focus on Layer-2 Protocols. ETHZilla plans to leverage Ethereum’s Layer-2 (L2) networks to generate higher yields than…
3 / 13
Growth Potential and Stablecoin Expansion. Rudisill is bullish on Ether’s price trajectory, projecting that the cryptocurrency could reach…
4 / 13
Financial Strategy and Market Position. ETHZilla’s treasury strategy emphasizes scale. While BitMine Immersion Technologies leads with 2.
5 / 13
Broader Implications for Ethereum and Crypto Adoption. Rudisill believes more treasury companies will enter the Ether space, though he cautions that not…
6 / 13
Outlook and Future Prospects. ETHZilla’s pivot underscores the growing importance of Ethereum and stablecoins in global finance.
7 / 13
ETHZilla, formerly a struggling biotechnology company, has transformed into one of the world’s largest public Ethereum treasury firms.
8 / 13
Two months after the pivot, ETHZilla has become the eighth-largest Ethereum treasury company globally, holding over 102,000 ETH tokens.
9 / 13
The company’s strategy is not limited to holding Ether but actively putting it to work in L2 protocols to generate “substantially higher yield” than conventional staking.
10 / 13
ETHZilla’s move comes as stablecoins are becoming increasingly integral to the digital finance ecosystem.
11 / 13
Since pivoting into crypto, ETHZilla’s stock has rebounded, registering a 44% year-to-date gain. August 2025 marked its best month, with shares climbing to $10.70.
12 / 13
Governments and financial institutions are also expected to increase engagement with crypto, he added.
13 / 13
With over 102,000 ETH in its treasury and a focus on L2 deployment, ETHZilla exemplifies the trend of public firms leveraging cryptocurrency as a strategic financial asset.
The Currency Analytics
Want the full story?